Understanding regenerative medicine inside war zones
Thanks to a $2.4 million grant from the DoD, Rion is collaborating with the Mayo Clinic and the U.S. Army Medical Research Institute to study the company’s Exosome Product for service members. Dr. Atta Behfar, Rion CEO and cofounder, explains.
Want to get more stories like this
one? Get daily news updates from Healthcare IT News.
Most Read
Research
White Papers
Patient Engagement
Patient Engagement
Financial/Revenue Cycle Management
Webinars
Artificial Intelligence
